BIRC2 and non-small cell lung carcinoma: We have recently shown that API-1 facilitates c-FLIP degradation, induces apoptosis and enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human non-small cell lung cancer (NSCLC) cells [2].